Hacohen, Y; Messina, S; Gan, H-W; Wright, S; Chandratre, S; Leite, MI; Fallon, P; ... Hemingway, C; + view all Hacohen, Y; Messina, S; Gan, H-W; Wright, S; Chandratre, S; Leite, MI; Fallon, P; Vincent, A; Ciccarelli, O; Wassmer, E; Lim, M; Palace, J; Hemingway, C; - view fewer (2018) Endocrinopathies in paediatric-onset neuromyelitis optica spectrum disorder with aquaporin 4 (AQP4) antibody. Multiple Sclerosis Journal , 24 (5) pp. 679-684. 10.1177/1352458517726593.

Preview	Text Hacohen_et al AQP4 endocrinopathies R1 unmarked.pdf - Accepted Version Download (157kB) | Preview
	Slideshow (Images) Hacohen_et al AQP4 endo Figure 060517.pptx - Accepted Version Download (3MB)

Abstract

The involvement of the diencephalic regions in neuromyelitis optica spectrum disorder (NMOSD) may lead to endocrinopathies. In this study, we identified the following endocrinopathies in 60% (15/25) of young people with paediatric-onset aquaporin 4-Antibody (AQP4-Ab) NMOSD: morbid obesity (n = 8), hyperinsulinaemia (n = 5), hyperandrogenism (n = 5), amenorrhoea (n = 5), hyponatraemia (n = 4), short stature (n = 3) and central hypothyroidism (n = 2) irrespective of hypothalamic lesions. Morbid obesity was seen in 88% (7/8) of children of Caribbean origin. As endocrinopathies were prevalent in the majority of paediatric-onset AQP4-Ab NMOSD, endocrine surveillance and in particular early aggressive weight management is required for patients with AQP4-Ab NMOSD.

Download activity - last month

Export as CSVXMLJSON

Download activity - last 12 months

Export as JSONXMLCSV

Downloads by country - last 12 months

Export as XMLJSONCSV

Archive Staff Only

View Item